Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexandra M Miller

Showing results (21-30 of 35) with videos related to

Pageof 4
Sort By:
Med (New York, N.Y.)|February 26, 2025
Ultra-rapid droplet digital PCR enables intraoperative tumor quantificationZachary R Murphy, Emilia C Bianchini, Andrew Smith, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 30, 2022
Dynamic Mutational Landscape of Cerebrospinal Fluid Circulating Tumor DNA and Predictors of Survival after Proton Craniospinal Irradiation for Leptomeningeal MetastasesN Ari Wijetunga, Alexander G Goglia, Nils Weinhold, et al.
JCI Insight|May 17, 2016
Multiplexed immunofluorescence delineates proteomic cancer cell states associated with metabolismAnup Sood, Alexandra M Miller, Edi Brogi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 12, 2024
Systematic Review of Cerebrospinal Fluid Biomarker Discovery in Neuro-Oncology: A Roadmap to Standardization and Clinical ApplicationNicholas Mikolajewicz, Patricia P Yee, Debarati Bhanja, et al.
BMC Cancer|January 14, 2022
Routine use of low-dose glucarpidase following high-dose methotrexate in adult patients with CNS lymphoma: an open-label, multi-center phase I studyLauren R Schaff, Mina Lobbous, Dean Carlow, et al.
Acta Neuropathologica|October 13, 2023
CDKN2A/B mutations and allele-specific alterations stratify survival outcomes in IDH-mutant astrocytomasRichard A Hickman, Erika Gedvilaite, Ryan Ptashkin, et al.
Acta Neuropathologica Communications|November 10, 2020
Genetic and epigenetic landscape of IDH-wildtype glioblastomas with FGFR3-TACC3 fusionsDouglas A Mata, Jamal K Benhamida, Andrew L Lin, et al.
Neuro-Oncology Advances|January 4, 2021
Preclinical and first-in-human-brain-cancer applications of [<sup>18</sup>F]poly (ADP-ribose) polymerase inhibitor PET/MRRobert J Young, Paula Demétrio De Souza França, Giacomo Pirovano, et al.
Journal for Immunotherapy of Cancer|June 6, 2025
In-depth characterization of vaccine-induced neoantigen-specific T cells in patients with IDH1-mutant glioma undergoing personalized peptide vaccinationHenning Zelba, Borong Shao, Armin Rabsteyn, et al.
JAMA Oncology|September 4, 2025
Proton Craniospinal Irradiation for Patients With Leptomeningeal Metastasis: A Randomized Clinical TrialJonathan T Yang, Divya Yerramilli, Elena Pentsova, et al.
Pageof 4

Showing results (21-30 of 35) with videos related to

Sort By:
Pageof 4
Med (New York, N.Y.)|February 26, 2025
Ultra-rapid droplet digital PCR enables intraoperative tumor quantificationZachary R Murphy, Emilia C Bianchini, Andrew Smith, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 30, 2022
Dynamic Mutational Landscape of Cerebrospinal Fluid Circulating Tumor DNA and Predictors of Survival after Proton Craniospinal Irradiation for Leptomeningeal MetastasesN Ari Wijetunga, Alexander G Goglia, Nils Weinhold, et al.
JCI Insight|May 17, 2016
Multiplexed immunofluorescence delineates proteomic cancer cell states associated with metabolismAnup Sood, Alexandra M Miller, Edi Brogi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 12, 2024
Systematic Review of Cerebrospinal Fluid Biomarker Discovery in Neuro-Oncology: A Roadmap to Standardization and Clinical ApplicationNicholas Mikolajewicz, Patricia P Yee, Debarati Bhanja, et al.
BMC Cancer|January 14, 2022
Routine use of low-dose glucarpidase following high-dose methotrexate in adult patients with CNS lymphoma: an open-label, multi-center phase I studyLauren R Schaff, Mina Lobbous, Dean Carlow, et al.
Acta Neuropathologica|October 13, 2023
CDKN2A/B mutations and allele-specific alterations stratify survival outcomes in IDH-mutant astrocytomasRichard A Hickman, Erika Gedvilaite, Ryan Ptashkin, et al.
Acta Neuropathologica Communications|November 10, 2020
Genetic and epigenetic landscape of IDH-wildtype glioblastomas with FGFR3-TACC3 fusionsDouglas A Mata, Jamal K Benhamida, Andrew L Lin, et al.
Neuro-Oncology Advances|January 4, 2021
Preclinical and first-in-human-brain-cancer applications of [<sup>18</sup>F]poly (ADP-ribose) polymerase inhibitor PET/MRRobert J Young, Paula Demétrio De Souza França, Giacomo Pirovano, et al.
Journal for Immunotherapy of Cancer|June 6, 2025
In-depth characterization of vaccine-induced neoantigen-specific T cells in patients with IDH1-mutant glioma undergoing personalized peptide vaccinationHenning Zelba, Borong Shao, Armin Rabsteyn, et al.
JAMA Oncology|September 4, 2025
Proton Craniospinal Irradiation for Patients With Leptomeningeal Metastasis: A Randomized Clinical TrialJonathan T Yang, Divya Yerramilli, Elena Pentsova, et al.
Pageof 4